Organon cuts outlook

 

• Third quarter 2023 revenue of $1,519 million
• Third quarter 2023 diluted earnings per share of $0.23 and non-GAAP Adjusted diluted earnings per share of $0.87
• Adjusted EBITDA of $447 million
• Board of Directors declares quarterly dividend of $0.28 per share
• Full year 2023 financial guidance ranges updated:
• Revenue range narrowed and lowered to $6.15 billion to $6.25 billion
• Adjusted EBITDA margin range narrowed and lowered to 30.5% to 31.5%

https://www.businesswire.com/news/home/20231102429565/en/